ADR Biomedical Holdings (TSE:3750) Other Current Assets: 円9.32 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
31 GF Score
Price 円778.00
GF Value 円39.95
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings Other Current Assets?

ADR Biomedical Holdings TSE:3750 -2.75% 31 Other Current Assets is 円9.32 Mil as of Mar. 2026. GuruFocus rates TSE:3750 with a GF Score™ of 31/100 and a GF Value™ of 円39.95 (Significantly Overvalued). The stock has 9 warning signs investors should review.

ADR Biomedical Holdings's other current assets for the quarter that ended in Mar. 2026 was 円9.32 Mil.

ADR Biomedical Holdings's quarterly other current assets increased from Mar. 2025 (円203.44 Mil) to Sep. 2025 (円215.78 Mil) but then declined from Sep. 2025 (円215.78 Mil) to Mar. 2026 (円9.32Mil).

ADR Biomedical Holdings's annual other current assets declined from Mar. 2024 (円227.59 Mil) to Mar. 2025 (円203.44 Mil) declined from Mar. 2025 (円203.44 Mil) to Mar. 2026 (円9.32 Mil).


ADR Biomedical Holdings Other Current Assets Related Terms


ADR Biomedical Holdings Other Current Assets Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Other Current Assets Chart

ADR Biomedical Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 414.08 35.80 227.59 203.44 9.32

ADR Biomedical Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 227.59 155.07 203.44 215.78 9.32
TSE:3750
31GF Score
ADR Biomedical Holdings Inc TSE:3750
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADR Biomedical Holdings Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of 円9.32 Mil mean?
ADR Biomedical Holdings (TSE:3750) has a Other Current Assets of 円9.32 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on ADR Biomedical Holdings.
Is ADR Biomedical Holdings' Other Current Assets too high?
ADR Biomedical Holdings' current Other Current Assets is 円9.32 Mil. Overall, ADR Biomedical Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' Other Current Assets compare to VRTX and REGN?
ADR Biomedical Holdings' Other Current Assets of 円9.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Biotechnology company?
A good Other Current Assets depends on the Biotechnology industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on ADR Biomedical Holdings. ADR Biomedical Holdings's current Other Current Assets is 円9.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.95, compared to a current price of 円778.00 — trading 1847.4% above its estimated fair value. The current Other Current Assets is 円9.32 Mil. ADR Biomedical Holdings' overall GF Score™ is 31/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Other Current Assets is 円9.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円778.00 is trading 1847.4% above its estimated GF Value™ of 円39.95. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • Other Current Assets: 円9.32 Mil
  • GF Value™: 円39.95 vs. price of 円778.00 (1847.4% above fair value)
  • GF Score™: 31/100 with 9 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
31GF Score

Get the complete analysis for TSE:3750

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円778.00
Price
円39.95
GF Value